ReviewJCO precision oncology2019

Phase III Precision Medicine Clinical Trial Designs That Integrate Treatment and Biomarker Evaluation.

Mei-Yin C Polley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.